MHRA launches initiative to improve female participation in trials
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is launching a Women’s Health Programme to boost female participation in…
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is launching a Women’s Health Programme to boost female participation in…
Altis Labs’ artificial intelligence (AI)-powered imaging endpoint has shown its ability to detect early, notable treatment effects more effectively than…
Novocure’s stock has dropped more than 15% after its Phase III glioblastoma study of Optune Gio failed to show benefit…
Following news that started brewing last week, Dr Marty Makary has officially resigned from his post as commissioner of the…
CVRx’s stock has risen nearly 20% after the company revealed that its heart failure device is set to be investigated…
One of the main challenges for medical device developers is ensuring clinical trials meet the expectations of all regulatory authorities…
US President Donald Trump's 200% tariff threat on the pharmaceutical industry is a "shock" that will reverberate through global supply…
US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable. The…
Experts are emphasising that safeguarding patient data from corporations and cyberattacks is vital for the NHS to create a single…
European residents must be fully informed to properly trust the incoming European Health Data Space (EHDS) regulation if it is…